LOGO.png
Nemaura Medical to Present at the 24th Annual H.C. Wainwright Global Investment Conference
September 06, 2022 08:30 ET | Nemaura Medical, Inc
Loughborough, England, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable...
LOGO.png
Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update
August 15, 2022 08:30 ET | Nemaura Medical, Inc
Loughborough, England, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
LOGO.png
Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker Term for its Metabolic Health Program
July 21, 2022 08:00 ET | Nemaura Medical, Inc
Loughborough, England, July 21, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
LOGO.png
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022
June 30, 2022 08:00 ET | Nemaura Medical, Inc
Loughborough, England, June 30, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
LOGO.png
Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding
May 23, 2022 06:30 ET | Nemaura Medical, Inc
Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
LOGO.png
Nemaura Medical to Present at the H.C. Wainwright Global Hybrid Investment Conference
May 19, 2022 08:00 ET | Nemaura Medical, Inc
Loughborough, England, May 19, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
LOGO.png
Nemaura Medical to Present at the Planet MicroCap Showcase 2022
April 25, 2022 08:30 ET | Nemaura Medical, Inc
Loughborough, England, April 25, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
LOGO.png
Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference
March 24, 2022 16:24 ET | Nemaura Medical, Inc
Loughborough, England, March 24, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
LOGO.png
Nemaura Medical Wins Innovation Awards
February 28, 2022 08:00 ET | Nemaura Medical, Inc
Loughborough, England, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update
February 14, 2022 08:00 ET | Nemaura Medical, Inc
Loughborough, England, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...